Inventor · disambiguated record
Eduardo J. Martinez
Also filed as: MARTINEZ EDUARDO · MARTINEZ EDUARDO J
26 granted patents·23 pending applications·78 citations·filing 1997–2024
94Inventor score
Files withMICROBIA INC10RGENIX INC9EUCLISES PHARMACEUTICALS INC6INSPIRNA INC6BRISTOL MYERS SQUIBB CO4
Top patents by PatentIndex Score
49 records- 0194US11878956B2Metal salts and uses thereofINSPIRNA INC·Filed 2022·Granted Jan 23, 2024·2 cites·10 claims
- 0293US11845770B2Ascaroside derivatives and methods of useCALIFORNIA INST OF TECHN·Filed 2022·Granted Dec 19, 2023·2 cites·21 claims
- 0393US9884813B1Pharmaceutically acceptable salts of B-guanidinopropionic acid with improved properties and uses thereofRGENIX INC·Filed 2017·Granted Feb 6, 2018·11 cites·28 claims
- 0492US11174220B2Metal salts and uses thereofINSPIRNA INC·Filed 2020·Granted Nov 16, 2021·2 cites·7 claims
- 0591US11459292B2Metal salts and uses thereofINSPIRNA INC·Filed 2021·Granted Oct 4, 2022·2 cites·5 claims
- 0690US12258303B2Metal salts and uses thereofINSPIRNA INC·Filed 2023·Granted Mar 25, 2025·1 cites·19 claims
- 0790US9827217B2Pharmaceutically acceptable salts of B-guanidinopropionic acid with improved properties and uses thereofRGENIX INC·Filed 2016·Granted Nov 28, 2017·8 cites·18 claims
- 0887US10669296B2LXR agonists and uses thereofRGENIX INC·Filed 2015·Granted Jun 2, 2020·6 cites·19 claims
- 0981US7320972B24-Biarylyl-1-phenylazetidin-2-onesMICROBIA INC·Filed 2004·Granted Jan 22, 2008·24 cites·71 claims
- 1077US10377715B218-20 member bi-polycyclic compoundsHARO PHARMACEUTICAL INC·Filed 2017·Granted Aug 13, 2019·3 cites·13 claims
- 1168US12473323B2Ascaroside derivatives and methods of useCALIFORNIA INST OF TECHN·Filed 2020·Granted Nov 18, 2025·0 cites·23 claims
- 1264US11685726B2Pharmaceutical compositions of 6-(2-(2H-tetrazol-5-yl)ethyl)-6-fluorodecahydroisoquinoline-3-carboxylic acid and ester derivatives thereofSEA PHARMACEUTICALS LLC·Filed 2022·Granted Jun 27, 2023·0 cites·20 claims
- 1363US10752591B218-20 member bi-polycyclic compoundsHARO PHARMACEUTICAL INC·Filed 2019·Granted Aug 25, 2020·0 cites·11 claims
- 1463US5856507AMethods for the preparation of biphenyl isoxazole sulfonamidesBRISTOL MYERS SQUIBB CO·Filed 1997·Granted Jan 5, 1999·12 cites·10 claims
- 1562US10954194B218-20 member bi-polycyclic compoundsHARO PHARMACEUTICAL INC·Filed 2019·Granted Mar 23, 2021·0 cites·19 claims
- 1662US9630896B22,5-dialkyl-4-H/halo/ether-phenol compoundsTANSNA THERAPEUTICS INC·Filed 2014·Granted Apr 25, 2017·0 cites·8 claims
- 1762US2020138759A1Pharmaceutically acceptable salts of beta-guanidinopropionic acid with improved properties and uses thereofRGENIX INC·Filed 2019·Application pending·0 cites
- 1861US10512623B2Pharmaceutically acceptable salts of B-Guanidinopropionic acid with improved properties and uses thereofRGENIX INC·Filed 2017·Granted Dec 24, 2019·0 cites·15 claims
- 1960US2025188018A1Formulations with improved stabilityINSPIRNA INC·Filed 2024·Application pending·0 cites
- 2058US9044464B2No-releasing guanidine-coxib anti-cancer agentsEUCLISES PHARMACEUTICALS INC·Filed 2013·Granted Jun 2, 2015·0 cites·19 claims
- 2156US2025074887A1Pharmaceutical compositions of 6-(2-(2h-tetrazol-5-yl)ethyl)decahydroisoquinoline-3-carboxylic acid and derivatives thereofSEA PHARMACEUTICALS LLC·Filed 2022·Application pending·0 cites
- 2254US10717704B2Inhibitors of creatine transport and uses thereofRGENIX INC·Filed 2019·Granted Jul 21, 2020·0 cites·14 claims
- 2353US2017056352A1PHARMACEUTICALLY ACCEPTABLE SALTS OF beta-GUANIDINOPROPIONIC ACID WITH IMPROVED PROPERTIES AND USES THEREOFRGENIX INC·Filed 2016·Application pending·0 cites
- 2452US10308597B2Inhibitors of creatine transport and uses thereofRGENIX INC·Filed 2015·Granted Jun 4, 2019·0 cites·16 claims
- 2551US11629118B2Formulations with improved stabilityINSPIRNA INC·Filed 2018·Granted Apr 18, 2023·0 cites·20 claims
- 2651US2017196835A1Combination of a chromene compound and a second active agentEUCLISES PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2751US2008167255A14-biarylyl-1-phenylazetidin-2-onesMICROBIA INC·Filed 2007·Application pending·0 cites
- 2849US2017174600A12,5-dialkyl-4-h/halo/ether-phenol compoundsTANSNA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2949US2022409650A1Compositions and methods for ascaroside modification of mammalian microbiotaHOLOCLARA INC·Filed 2020·Application pending·0 cites
- 3045US8859781B2No-releasing nonoate(nitrogen-bound)sulfonamide-linked-coxib anti-cancer agentsEUCLISES PHARMACEUTICALS INC·Filed 2013·Granted Oct 14, 2014·0 cites·26 claims
- 3145US2008200669A1Processes For Production of Phenolic 4-Biphenylylazetidin-2-OnesMICROBIA INC·Filed 2006·Application pending·0 cites
- 3244US2007161577A1Tethered dimers and trimers of 1,4-diphenylazetidin-2-onesMARTINEZ EDUARDO J·Filed 2004·Application pending·0 cites
- 3344US2007072812A1Quaternary salt derivatives of 1,4-diphenylazetidin-2-onesMICROBIA INC·Filed 2004·Application pending·0 cites
- 3443US2009186834A1Diphenylheterocycle cholesterol absorption inhibitorsMICROBIA INC·Filed 2006·Application pending·0 cites
- 3543US2017114019A118-20 member bi-polycyclic compoundsHARO PHARMACEUTICAL INC·Filed 2015·Application pending·0 cites
- 3642US2004106663A1Inhibitors of fungal invasionFiled 2003·Application pending·0 cites
- 3742US2008287663A1Process For Production Of 4-Biphenylyazetidin-2-OnesMICROBIA INC·Filed 2006·Application pending·0 cites
- 3841US5892106APreparation of 3-fluoro oxindole derivativesBRISTOL MYERS SQUIBB CO·Filed 1998·Granted Apr 6, 1999·4 cites·9 claims
- 3940US2019125745A1Treatment and diagnosis of cancerRGENIX INC·Filed 2015·Application pending·0 cites
- 4039US10266511B2No-releasing nitrooxy-chromene conjugatesEUCLISES PHARMACEUTICALS INC·Filed 2015·Granted Apr 23, 2019·0 cites·6 claims
- 4139US2009292135A1Organometal benzenephosphonate coupling agentsIRONWOOD PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 4239US2008194494A14-Biarylyl-1-Phenylazetidin-2-One Glucuronide Derivatives for HypercholesterolemiaMICROBIA INC·Filed 2006·Application pending·0 cites
- 4339US2009131395A1Biphenylazetidinone cholesterol absorption inhibitorsMICROBIA INC·Filed 2006·Application pending·0 cites
- 4439US2009099355A1Processes for Production of 4-(Biphenylyl)Azetidin-2-One Phosphonic AcidsMICROBIA INC·Filed 2006·Application pending·0 cites
- 4538US2009005321A1Phenylazetidinone DerivativesMICROBIA INC·Filed 2006·Application pending·0 cites
- 4637US2015197500A1No-releasing guanidine-chromene conjugatesEUCLISES PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 4736US6515136B1Methods for the preparation of biphenyl isoxazole sulfonamidesBRISTOL MYERS SQUIBB CO·Filed 1998·Granted Feb 4, 2003·1 cites·1 claims
- 4834US5808095APreparation of 3-fluoro oxindole derivativesBRISTOL MYERS SQUIBB CO·Filed 1997·Granted Sep 15, 1998·0 cites·5 claims
- 4931US2015197494A1No-releasing nitrooxy-methylene-linked-coxib conjugatesEUCLISES PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eduardo J. Martinez files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →